DEFAZIO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 13.522
AS - Asia 3.717
EU - Europa 3.285
SA - Sud America 1.067
Continente sconosciuto - Info sul continente non disponibili 458
AF - Africa 170
OC - Oceania 9
Totale 22.228
Nazione #
US - Stati Uniti d'America 13.179
SG - Singapore 1.585
IT - Italia 1.361
BR - Brasile 851
CN - Cina 801
HK - Hong Kong 525
DE - Germania 302
UA - Ucraina 299
SE - Svezia 271
RU - Federazione Russa 254
FI - Finlandia 230
FR - Francia 198
VN - Vietnam 182
GB - Regno Unito 159
CA - Canada 158
BD - Bangladesh 137
IN - India 116
AR - Argentina 60
CI - Costa d'Avorio 49
IQ - Iraq 49
EC - Ecuador 46
BE - Belgio 40
CO - Colombia 39
TR - Turchia 37
IE - Irlanda 35
ID - Indonesia 33
MX - Messico 33
TT - Trinidad e Tobago 33
PK - Pakistan 32
ZA - Sudafrica 30
VE - Venezuela 28
SA - Arabia Saudita 27
SV - El Salvador 24
PL - Polonia 23
TW - Taiwan 23
JP - Giappone 22
NL - Olanda 21
ES - Italia 20
CR - Costa Rica 19
MA - Marocco 19
PH - Filippine 19
IR - Iran 18
AE - Emirati Arabi Uniti 17
HN - Honduras 16
CL - Cile 14
CZ - Repubblica Ceca 14
TN - Tunisia 14
GT - Guatemala 13
NI - Nicaragua 12
UZ - Uzbekistan 12
AT - Austria 11
CW - ???statistics.table.value.countryCode.CW??? 11
IL - Israele 11
JM - Giamaica 11
MY - Malesia 11
SC - Seychelles 10
EG - Egitto 9
JO - Giordania 9
KE - Kenya 9
UY - Uruguay 9
LU - Lussemburgo 8
AU - Australia 7
ET - Etiopia 7
GP - Guadalupe 7
PE - Perù 7
PY - Paraguay 7
AL - Albania 6
AZ - Azerbaigian 6
DZ - Algeria 6
KR - Corea 6
PR - Porto Rico 6
EE - Estonia 5
LB - Libano 5
NG - Nigeria 5
NP - Nepal 5
BH - Bahrain 4
BO - Bolivia 4
KZ - Kazakistan 4
MD - Moldavia 4
PS - Palestinian Territory 4
SN - Senegal 4
DO - Repubblica Dominicana 3
GR - Grecia 3
KG - Kirghizistan 3
PT - Portogallo 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
GD - Grenada 2
GE - Georgia 2
GY - Guiana 2
KW - Kuwait 2
LT - Lituania 2
LY - Libia 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 21.759
Città #
Fairfield 1.321
Ashburn 1.211
Woodbridge 1.040
San Jose 940
Singapore 769
Houston 662
Jacksonville 648
Chandler 633
Seattle 535
Hong Kong 522
Milan 480
Cambridge 433
Ann Arbor 423
Wilmington 392
Council Bluffs 379
Dallas 322
New York 195
Rome 193
Beijing 179
Lawrence 165
Nanjing 165
Roxbury 165
Lauterbourg 164
Boardman 149
Nyköping 149
Los Angeles 130
Columbus 127
Des Moines 111
Santa Clara 110
Princeton 86
São Paulo 83
Ho Chi Minh City 67
Buffalo 62
San Diego 57
Helsinki 55
Chicago 52
Abidjan 49
Figino 47
Nanchang 46
Phoenix 46
Shenyang 45
Inglewood 43
Naples 43
Bari 42
Turin 41
Hebei 40
Brooklyn 38
Atlanta 36
Hanoi 36
Brussels 34
Toronto 34
Dublin 32
San Francisco 32
Jiaxing 29
Nuremberg 28
Montreal 27
Rio de Janeiro 26
Falkenstein 24
North Bergen 24
Taipei 22
Baghdad 21
London 21
Munich 21
Chennai 20
Frankfurt am Main 20
Quito 20
San Salvador 19
Warsaw 19
Chaguanas 18
Denver 18
Pittsburgh 18
Tokyo 18
Bologna 17
San Mateo 17
Belo Horizonte 16
Changsha 16
Johannesburg 16
Norwalk 16
Augusta 15
Campinas 15
Washington 15
Brasília 14
Curitiba 14
Dhaka 14
Orem 14
Ribeirão Preto 14
Tianjin 14
Turku 14
Charlotte 13
Dearborn 13
Guayaquil 13
Mexico City 13
Miami 13
San José 13
Boston 12
Guangzhou 12
Managua 12
Mokena 12
Palermo 12
Pune 12
Totale 14.662
Nome #
Assessment of voice and speech symptoms in early Parkinson’s disease by the Robertson dysarthria profile 228
Action tremor in Parkinson's disease: frequency and relationship to motor and non-motor signs 212
Bilateral striatal necrosis, dystonia and multiple mitochondrial DNA deletions: case study and effect of deep brain stimulation 203
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 182
Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings 181
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 175
Antineuronal antibody status and phenotype analysis in Tourette's syndrome 173
A comparative study of primary and secondary hemifacial spasm 173
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease 166
ANTINFLAMMATORY EFFECTS OF RIFNB-1B IN MULTIPLE SCLEROSIS: LONGITUDINAL CHANGES OF THE SERUM SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 (SICAM-1), TNFA AND T-CELL SUBSETS 164
Anti-basal ganglia antibodies and Tourette's syndrome: a voxel-based morphometry and diffusion tensor imaging study in an adult population 164
Personality disorders and somatization in functional and organic movement disorders 157
No association between essential tremor and migraine: A case-control study 156
Are nongenetic triggers for dystonia type-specific? A study exploring scoliosis in blepharospasm 154
Abnormal processing of the nociceptive input in Parkinson's disease: a study with CO2 laser evoked potentials 154
Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders 152
Agreement among neurologists on the clinical diagnosis of dystonia at different body sites 152
Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia 152
Camptocormia in Parkinson disease: an epidemiological and clinical study 151
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? 151
Onset and spread of dyskinesias and motor symptoms in Parkinson's disease 147
Antineuronal antibodies in cranial dystonia. 147
Cortical gray matter changes in primary blepharospasm: a voxel-based morphometry study 147
Abnormal tactile temporal discrimination in psychogenic dystonia 145
Relationship between eye symptoms and blepharospasm: a multicenter case-control study 143
The natural history of treated PD in an incident, community-based cohort: does the future begin? 143
"Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report 142
Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment 141
Headache in cranial and cervical dystonia 138
A family study on primary blepharospasm 138
Epidemiology of primary dystonia 137
The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort 136
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias 136
Frequency of familial aggregation in primary adult-onset cranial cervical dystonia 134
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. 134
Brain F-18 Fluorocholine PET/CT for the Assessment of Optic Pathway Glioma in Neurofibromatosis-1 133
Post-streptococcal 'complex' movement disorders: unusual concurrence of psychogenic and organic symptoms 133
Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing 132
The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia 131
La tossina botulinica nel recupero del piede equino-valgo da paralisi cerebrale infantile 129
Antinflammatory effects of rIFNb-1b in multiple sclerosis: longitudinal changes of the serum soluble Intercellular Adhesion Molecule-1 (sICAM-1), TNFa and T-cell subsets 128
Endocytosis of horseradish peroxidase by brain microvascular and umbilical vein endothelial cells in culture: an ultrastructural and morphometric study 127
EPIDEMIOLOGY OF PRIMARY BLEPHAROSPASM 126
Development and validation of a clinical guideline for diagnosing blepharospasm 125
L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?. 124
Is increased blinking a form of blepharospasm? 124
Psychiatric disorders in patients with essential tremor 124
Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasm 121
Epidemiology of primary and secondary dystonia 121
How pain arises in Parkinson's disease 121
Pain and motor complications in Parkinson's disease 120
Do primary adult-onset focal dystonias share aetiological factors? 120
Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a 120
Defective temporal processing of sensory stimuli in DYT1 mutation carriers: a new endophenotype of dystonia? 120
Spontaneous pain, pain threshold, and pain tolerance in Parkinson's disease 119
Midbrain SERT in degenerative parkinsonisms: A 123I-FP-CIT SPECT study 119
Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's disease 118
Ataxia in posterior circulation stroke: clinical-MRI correlations 117
Assessing the role of DRD5 and DYT1 in two different case-control series with primary blepharospasm 117
The epidemiology of pain in Parkinson's disease 116
Disease modeling in functional movement disorders 116
Time processing in children with Tourette's syndrome 116
The epidemiology of primary dystonia: current evidence and perspectives 116
Eye symptoms in relatives of patients with primary adult-onset dystonia 116
Pathophysiology of somatosensory abnormalities in Parkinson disease. 115
Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia 115
Primary Cervical dystonia and scoliosis: a multicenter case-control study 115
Long-term assessment of the risk of spread in primary late-onset focal dystonia 114
Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture 114
Phenotypic overlap in familial and sporadic primary adult-onset extracranial dystonia 113
Influence of age on the association between primary hemifacial spasm and arterial hypertension 113
Manganese toxicity in serumless dissociated mesencephalic and striatal primary culture 112
Soluble adhesion molecules in Gilles de la Tourette's syndrome 112
The influence of electroencephalographic focus laterality on efficacy of carbamazepine in complex partial and secondarily generalized tonic-clonic seizures 111
Fatigue in Parkinson's disease 111
The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder 111
Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24) 111
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia 110
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions 110
Sleep and cranial dystonia 109
Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: a reappraisal of genetic testing criteria . 109
Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group 109
Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials 109
Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials 108
Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia 108
Quality of sleep in primary focal dystonia: a case-control study 108
Botulinum A toxin for the so-called apraxia of lid opening 108
Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses 107
Temporal discrimination in patients with dystonia and tremor and patients with essential tremor 106
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 106
Mirror movements in patients with Parkinson's disease 106
Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene 105
Primary hemifacial spasm and arterial hypertension: a multicenter case-control study 105
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia 105
Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening 105
Blepharospasm in bardet-biedl syndrome: a case report 104
Holmes' tremor associated to HSV-1 cerebral pedunculitis: a case report 104
Epidemiology of primary blepharospasm 103
Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels 102
Epidemiology of primary and secondary dystonia 102
Totale 12.972
Categoria #
all - tutte 83.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022796 0 0 0 0 58 96 29 47 104 90 163 209
2022/20231.499 272 122 46 172 221 204 7 148 236 5 36 30
2023/2024630 51 113 27 119 35 140 4 19 2 11 29 80
2024/20252.382 34 41 223 76 51 176 161 190 99 111 387 833
2025/20266.408 712 250 455 473 511 349 616 231 757 606 402 1.046
2026/20273.308 466 602 752 1.462 26 0 0 0 0 0 0 0
Totale 22.228